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It has been hypothesized that programmed cell death (PCD), an active cell suicide process occurring in place of necrosis, can be associated with 
the pathogenesis of acquired immunodeticiency syndrome (AIDS). The entry of human immunodeficiency virus (HIV) into competent cells is 
mediated by the CD4 molecule present on the surface of certain lymphocyte subpopulations as well as on some cultured cell lines, e.g. U937 
myelomonocytic ells. The present paper focuses on some specific aspects of PCD induced by the cytokine tumor necrosis factor (TNF). The results 
obtained indicate that the exposure of U937 cells to cycloheximide facilitates TNF-mediated PCD via a short term cell death program and modifies 
the expression of CD4 surface molecules. This change in surface antigen expression, manifested by internalization of the CD4 molecule, occurs 
in cells in which apoptosis has been triggered, but not in cells undergoing necrosis. These results indicate that the progression of cell death could 
be associated with specific alterations of certain surface molecules and could have a role in the entry of HIV into cells. 
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1. INTRODUCTION 
Programmed cell death (PCD) is defined as a cell 
suicide process which is an alternative to necrosis and 
is characterized by a specific series of intracellular 
events leading ultimately to DNA fragmentation in 
multiples of 200 base pairs. It is postulated that PCD, 
also termed apoptosis, must be considered as an active 
process since it needs protein synthesis to occur [l] and, 
in contrast to necrosis, is accompanied by membrane 
and organelle integrity. The apoptotic process can be 
induced experimentally in vitro by using certain chemi- 
cal agents, e.g. tumor necrosis factor (TNF) [2] and can 
be prevented, in most cases, by protein synthesis inhib- 
itors such as cycloheximide [3]. More recently, it has 
been hypothesized that PCD may play a central role not 
only in embryonic development, but also in neoplastic 
proliferation [2] and in the pathogenesis of acquired 
immune deficiency syndrome (AIDS) [4]. 
The lymphocyte differentiation antigen CD4 is ex- 
pressed mainly by a subset of T-lymphocytes restricted 
to the class II major histocompatibility complex and on 
some cell lines of macrophage-monocyte lineage [5]. 
CD4 is also involved in several cell processes uch as 
thymocyte ontogeny and peripheral T-cell activation as 
well as being the receptor for human immunodeficiency 
virus (HIV) [6]. The mechanisms regulating CD4 mole- 
cule expression are not clearly understood. However, it 
is believed that this antigen is normally excluded from 
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the endocytic pathway in lymphoid cells, but that it can 
be constitutively internalized and recycled in non-lym- 
phoid cells and can be down-modulated in certain ex- 
perimental conditions [7]. 
The aim of the present work was to investigate the 
importance of active protein synthesis during TNF-me- 
diated PCD of HIV-responsive U937 cells and the anti- 
genie characteristic of the plasma membrane during this 
process. 
2. MATERIALS AND METHODS 
2.1. Cells and treatments 
U937 cells, a monomyelocytic human cell line, were grown at 37°C 
as previously reported [8]. 24 h after seeding, cell cultures were treated, 
by direct addition to the culture medium, with cycloheximide (CHX, 
4pM), a tumor necrosis factor (cc TNF, 50 U/ml). Menadione (MEN, 
2-methyl-naphtoquinone) was diluted in DMSO and a concentration 
of 200 PM was used. Corresponding amounts of DMSO alone were 
considered as controls. All chemicals were purchased by Sigma. In 
order to evaluate the effects of protein synthesis inhibitors during 
apoptosis, cells were either first exposed for two hours to CHX and 
then to TNF which was added to the medium, or to CHX and TNF 
together. Samples were collected after 4 and 6 h of TNF treatment. 
Cells treated with CHX or TNF alone for the same lengths of time 
were considered as controls. In order to test the effects of prolonged 
exposure of the TNF alone, cells were treated with TNF for 96 h and 
demonstrated to undergo apoptosis, as previously reported [2]. In 
order to evaluate differences between necrosis and apoptosis, the ef- 
fects of MEN (up to 3 h), which is capable of inducing necrosis [9], 
were also examined. 
2.2. DNA gel electrophoresis 
Cells, washed in PBS, were lysed in 0.5 ml of lysis buffer (10 mM 
Tris pH 7.4, 1 mM EDTA, pH 8.0,0.2% Triton X-100) with proteinase 
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K (100 &ml) for 1 h at room temperature and were centrifuged at 
13,000 r.p.m. for 15 min, in order to separate high molecular weight 
chromatin from the nucleosomal DNA fragments. DNA was ex- 
tracted and then separated overnight by electrophoresis on 1% agarose 
gel as previously described [8]. 
2.3. Flow cytometry 
Fluorescence measurements were performed on a FACScan flow 
cytometer (Becton Dickinson) and data were recorded by Hewlett 
Packard computer using a specific FACScan research software. DNA 
labeling: about lo6 cells were pelleted and fixed in 2 ml ice-cold 70% 
ethanol for 30 min. The cells were then centrifuged, washed in PBS 
and resuspended in 1 ml PBS containing 100 ,@ml propidium iodide 
(Sigma), 1 mg/ml RNAse (Sigma) and incubated at 37°C for 30 min. 
Red fluorescence (> 610 nm) was recorded. Pulse shape analysis (pulse 
width and area) was performed in order to eliminate the signal from 
cell clumps. Surface antigens labeling: the antibodies used were: anti 
CDCFITC and anti CD3-FITC (DAKO), anti CD71 (Boehringer 
Mannheim) and goat-anti mouse-FITC (F(ab’), specific) (Sigma). 
About lo6 cells for each sample were washed in ice-cold PBS, pelleted 
and incubated with antibodies diluted 15 (50 ~1 of inal suspension) 
for 30 min in an ice bath. For anti CD71, a second incubation with 
GAM-FITC (diluted 150) was performed. Finally, cells were washed 
3 times in ice-cold PBS and green fluorescence (535 nm) was recorded. 
Supravital staining of cells was performed by adding propidium iodide 
before surface antigen analysis. Only viable cells which excluded pro- 
pidium iodide were considered. 
2.4. Fluorescence microscopy 
Control and treated cells were seeded on glass coverslips coated with 
polylysine. For CD4 staining, after adhesion to the glass surface, cells 
were fixed at 4°C with 3.7% formaldehyde in PBS @H 7.4) for 10 min 
at room temperature, washed and directly prepared for fluorescence 
or confocal microscopy (Sarastro 2000 confocal aser scanning micro- 
scope) observation. For intracellular localization, after fixation and 
washing, cells were permeated with 0.5% Triton X-100 (Sigma) in PBS 
for 5 min at room temperature. Cells were then incubated with CD4- 
FITC (Dako) at 37°C for 30 min. In order to evaluate PCD, Hoechst 
33258 dye analysis was used [lo]. After washing, all the samples were 
mounted with glycerol-PBS (1:l) and observed with a Nikon Micro- 
phot fluorescence microscope. 
Fig. 1. Percent apoptosis in U937 cells after exposure to CHX (8 h), 
TNF (8 h), MEN (3 h), TNF (96 h), CHX together with TNF 
(CHX + TNF) (8 h), and CHX (2 h) followed by TNF (6 h) 
(CHX + TNF). Apoptosis was determined by counting the number 
of cells containing a nucleus with DNA fragmentation as determined 
by Hoechst staining with respect o the total number of cells examined 
(at least 200). Control cells are not shown since less than 2% of these 
cells are spontaneously apoptotic. The average value of each experi- 
ment, which was repeated at least three times, is shown. 
1 2 3 4 5 6 7 8 9 
Fig. 2. DNA fragmentation in U937 cells. Untreated cells (lane 2 and 
lane 8), or cells treated with MEN 3 h (lane 3), CHX 8 h (lane 4), TNF 
8 h (lane 5), CHX (2 h) + TNF (6 h) (lane 6), CHX together with TNF 
8 h (lane 7), and TNF 96 h (lane 9). A Hind111 digest of &DNA 
provided molecular weight standards (lane 1). 
3. RESULTS 
An analysis of cell death and accompanying surface 
antigen expression was carried out by using different 
methodological approaches. First, an evaluation of the 
temporal progression of TNF-induced PCD (ranging 
from 4 h to 96 h) with and without the presence of 
protein synthesis inhibitors (CHX) was conducted in 
U937 cells. Second, an analysis of CD4, CD3 and CD71 
membrane antigenic expression as well as possible 
changes in the structural properties of the plasma mem- 
brane during apoptosis were carried out. 
3.1. PCD analysis 
Apoptosis induced by various experimental condi- 
tions was investigated in U937 cells by means of flow 
cytometry, gel electrophoresis and fluorescence micros- 
copy. Neither CHX or TNF administered alone were 
capable of inducing significant PCD in the cultured cells 
after short time intervals (8 h) while TNF treatment 
could cause significant cell death after longer times (96 
h). In fact, when either CHX or TNF alone were added 
to the cultures for 8 h, little PCD was observed (Fig. 1). 
As an additional control, oxidative stress-induced ne- 
crosis [9] was also evaluated in these cells by using the 
quinone menadione. Apoptotic cell death was not sig- 
nificant after 3 h of treatment with menadione (Fig. 1). 
In contrast, fluorescence analysis by Hoechst staining 
(not shown) displayed over 50% of apoptotic cells after 
96 h of TNF treatment (Fig. 1). Base pair fragmentation 
was also confirmed by the results obtained by gel elec- 
trophoresis (Fig. 2). In addition, experiments in which 
CHX was either given together (8 h, CHX + TNF) or 
in sequence (2 h CHX followed by 6 h TNF, 
CHX + TNF) demonstrate that protein synthesis inhi- 
bition can increase the percentage of TNF-induced 
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Fig. 3. DNA histograms obtained by flow cytometric analysis in U937 
cells. Superimposed white profile of control cells and black profile of 
cells after treatment with CHX + TNF are shown. Sub Gl peak 
corresponds to cells undergoing PCD. 
apoptosis in U937 cells (Figs. 1 and 2, Hoechst staining 
not shown). Apoptosis was also confirmed by flow cy- 
tometry analysis which showed the formation of the 
typical broad hypodiploid DNA peak (sub G1 peak) 
typical of DNA base pair fragmentation (Fig. 3). In- 
creasing the exposure times up to 12 h (2 h CHX + 
10 h TNF) resulted in complete cellular disruption (not 
shown). Reversing the sequence (TNF followed by 
CHX) was ineffective in inducing short-term (8 h) apo- 
ptosis. 
3.2. Plasma membrane analyses 
The expression of the CD3, CD4 and CD71 surface 
antigens was evaluated in U937 cells undergoing PCD 
induced by both protocols described above, as well as 
in the same cells undergoing necrosis. These antigens 
were chosen because they are important in normal cell 
function and because their expression follows different 
physiological pathways. Flow cytometry results demon- 
strate that these antigens are expressed in a different 
manner during the apoptotic process studied here. In 
fact, transferrin receptor (CD71) as well as CD3 expres- 
sion remained unchanged in all apoptotic cells (Fig. 
4A,B). In contrast, when the association CHX + TNF 
was used, the decrease of the CD4 molecule on the cell 
surface was much more significant (P C< 0.01; Fig. 4C) 
with respect to short treatments with CHX or TNF 
alone (8 h and 8 h, Fig. 4D,E, respectively). In addition, 
in order to rule out the possibility that the redistribution 
of the CD4 receptors could merely be related to the cell 
injury process and in order to evaluate differences be- 
tween PCD and necrosis, experimental analyses were 
also performed in cells undergoing menadione-induced 
necrosis [9]. In this case, no changes were detected in 
antigen expression by flow cytometry (Fig. 4F). Fur- 
thermore, as demonstrated by immunofluorescence 
confocal laser scanning microscopy (Fig. 5), a remarka- 
ble positivity for CD4 antigen was detected in the cell 
cytoplasm of cells exposed to CHX + TNF, with re- 
spect to control cells. In fact, fluorescent spots in the cell 
Fig. 4. Flow cytometric fluorescence histograms of U937 cells stained with anti-CD71 (A) anti-CD3 (B) and anti-CD4 (C, D, E and F). Overlay 
histograms (empty profiles) represent control cells while filled histograms represent cells treated with CHX + TNF (A, B and C), CHX (D), TNF 
(E) and menadione (F). In all the experiments 10,000 cells were analyzed using the same fluorescence gain. 
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Fig. 5. Confocal laser scanning microscopy of unpermeated (a,c) and 
Triton-permeated (b,d) U937 cells. In control samples, a single full 
field optical section allowed visualization of scattered fluorescent 
spots representing CD4 antigen on either the surface of unpermeated 
cells (a) or marginalized in certain regions of the cytoplasm of perme- 
ated cells (b). In contrast, cells undergoing PCD after CHX + TNF 
treatment, displayed a marked decrease of CD4 fluorescence on the 
surface of unpermeated cells (c) while the intracellular presence of this 
antigen in permeated cells appeared notably increased (d). 
cortical regions after both staining procedures, i.e. un- 
permeated (surface) and permeated (intracytoplasmic) 
cells (Fig. 5a,b) were visible, while fluorescent labeling 
of CD4 molecules in CHX + TNF-exposed cells under- 
going PCD appeared completely modified, the antigen 
being easily observable intracellularly in permeated cells 
(Fig. 5c,d). This could signify that most of the CD4 
molecules were internalized. Furthermore, in order to 
test the possibility that TNF-induced cell death could 
directly modify CD4 molecule regulation at different 
times, shorter exposure times with CHX and TNF 
(CHX 2 h -+ TNF 4 h, Fig. 6A) and exposures of 48 and 
96 h with TNF alone were conducted and CD4 as well 
as CD71 expression were evaluated. No changes were 
induced by this treatment on the CD4 molecule at 48 h 
(Fig. 6B) while at 96 h CD4 expression was modified 
(Fig. 6C). Finally, no variations of CD71 expression 
were noted at both time periods (not shown). 
4. DISCUSSION 
4.1. Apoptosis 
The results reported in this paper suggest that  ‘slow’ 
PCD mechanism, induced by TNF alone, dependent on 
protein synthesis, and a ‘fast’ PCD process induced by 
CHX + TNF, independent of active protein synthesis, 
but still involving DNA fragmentation, can occur in 
U937 cells. In fact, various mechanisms of apoptotic cell 
death with different biochemical and structural features 
were previously hypothesized [lo]. These cell death pro- 
grams can be induced by certain compounds or experi- 
mental conditions and the possibility of ‘fast’ protein 
synthesis-independent PCDs as well as ‘slow’ death 
mechanisms were previously suggested [ 11,121. Further- 
more, the ‘spontaneous’ commitment o PCD occurring 
in some cell lines (e.g. in HL60 leukemic cells) must also 
be taken into account. The U937 line, widely used for 
in vitro maintenance of HIV since 1987 [5], displays a 
low number of cells undergoing spontaneous PCD. For 
this reason as well as for the fact that these cells are able 
to trigger short term apoptosis after CHX + TNF treat- 
ment, U937 cells can provide an interesting model for 
the study of the HIV-PCD association [13]. 
4.2. CD4 internalization 
In contrast to human lymphocytes, T cell lines nor- 
mally show very little endocytosis of CD4 molecule 
which in fact is not internalized efficiently [7]. However, 
as is demonstrated in this report, CD4 can be internal- 
ized quite efficiently by U937 cells. Thus, the study of 
U937 cells could demonstrate that CD4 internalization 
may be an important route for HIV entry into these 
cells. Furthermore, in view of the close relationship be- 
tween HIV and PCD, it can be hypothesized that, in 
certain conditions, the committment o PCD can play 
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Fig. 6. Flow cytometric fluorescence histograms of U937 cells stained with antiCD4. Overlay histograms (empty profiles) represent control cells. 
(a) Cells treated with the sequence CHX (2 h) + TNF (4 h). (b) Cells treated with TNF for 48 h. (c) Cells treated with TNF for 96 h. 
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an important role in HIV pathogenesis by a mechanism 
triggering CD4 internalization. 
The CD4 molecule is a type I transmembrane protein 
which can interact with protein tyrosine kinase p561ck, 
a member of the src family. It was previously observed 
that CD4 can be internalized via coated pits [7] and can 
be down-regulated in certain experimental conditions. 
In particular, modulation was demonstrated in human 
peripheral blood lymphocytes after stimulation with 
phorbol esters, anti-CD4 monoclonal antibodies, gan- 
gliosides or HIV [14,15]. The role of phosphorylation 
in causing the dissociation of ~56’“~ from the complex 
and determining the CD4 internalization still appears to 
be controversial [ 161. 
The results reported here demonstrating a PCD-asso- 
ciated internalization of CD4 could be partially ex- 
plained by considering relationships between reactive 
oxygen intermediates (ROI), PCD and HIV pathogene- 
sis. In fact, it is known that TNF exerts some of its 
effects by stimulating production of ROI [17]. It can 
thus be hypothesized that TNF-induced ROI, as dem- 
onstrated previously for certain oxidizing agents [18], 
can contribute to CD4 internalization by activating 
p561ck, or preventing its dephosphorylation. Accord- 
ingly, the role of protein kinase C (PKC) activity in the 
outcome of PCD has been considered [19], but has still 
to be elucidated. In addition, ROI are also capable of 
potently and rapidly activating the multisubunit tran- 
scription factor NFkB which is present in the cytoplasm 
in a non-DNA-binding form, thus releasing the inhib- 
itory subunit IkB from the other subunits (p65 and P50) 
[20]. The replication of HIV is under control of NFkB 
and the activation of this enhancer factor by TNF and 
protein synthesis inhibitors such as CHX could there- 
fore lead to increased HIV expression [21]. 
In conclusion, the interrelationships between PCD 
and AIDS pathogenesis [4] as well as those between 
TNF exposure and viral progeny production [22] could 
partially be related to the short term apoptosis demon- 
strated here. In fact, specific apoptotic mechanisms 
could be permissive to HIV entry and infection. How- 
ever, it must also be considered that other mechanisms 
could exist which render the PCD abortive and maintain 
the cells viability once HIV-CD4 internalization has 
occurred. This possibility of a block of the programmed 
cell death process can be plausible from a general point 
of view [3,23,24] and cannot be ruled out for HIV- 
related PCD. This block of PCD could be associated to 
the internalization of CD4 which, in turn, is due to a 
protein tyrosine kinase activation or to a PKC activa- 
tion, processes which can also be induced by TNF alone 
after longer treatment [18,25]. This could partially ex- 
plain the role of CD4 in HIV entry and the chronic 
nature of HIV infection in competent cells. 
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